[ Price : $8.95]
FDA warns against using results from many genetic tests to predict how a patient will respond to a specific medication.[ Price : $8.95]
Federal Register notice: FDA classifies the meprobamate test system into Class 2 (special controls).[ Price : $8.95]
FDA permits the de novo marketing of 23andMes Personal Genome Service Pharmacogenetic Reports as a direct-to-consumer test for pro...[ Price : $8.95]
Federal Register notice: FDA classifies insulin therapy adjustment devices into Class 2 (special controls).[ Price : $8.95]
Federal Register notice: FDA withdraws two proposed medical device rules after determining that they are not currently considered ...[ Price : $8.95]
The HHS Inspector General recommends ways FDA can improve its policies and procedures to address medical device postmarket cyberse...[ Price : $8.95]
FDA says it is evaluating over 75 reports of battery shutdown and other issues with Maquet/Datascope intra-aortic balloon pumps.[ Price : $8.95]
FDA clears an OsteoRemedies 510(k) for the Remedy Spectrum GV Hip Spacer System and Spectrum GV Bone Cement, which are intended to...